Mission
THE IMPROVEMENT OF ACCESS TO AND DATA ABOUT THERAPEUTIC NEOANTIGEN CANCER VACCINES.
Public Charity
JAIME LEANDRO FOUNDATION FOR THERAPEUTIC CANCER VACCINES
JAIME LEANDRO FOUNDATION FOR THERAPEUTIC CANCER VACCINES, of CHAPEL HILL, NC, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $4.8M in revenue, $4.6M in expenses, $3.1M in total assets. 13 publicly reported grants to this organization, totaling roughly $510K, appear in IRS filings.
EIN: 853117614
CHAPEL HILL, NC
Cancer
NTEE: G30
Latest filing: 2025
Total Revenue$4.8M
Total Expenses$4.6M
Total Assets$3.1M
Grant Records13
Funding Total$510K
Filing Years2022–2025
Where $100 goes at Jaime Leandro Foundation for Therapeutic Cancer Vaccines
How Jaime Leandro Foundation for Therapeutic Cancer Vaccines divides every $100 it spends, from its own Form 990 filings, averaged across 4 years.
$100
Programs
the work itself
<$1
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $100 for programs
$100
Compassionate access vaccine program
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
$135,000
GENERAL SUPPORT
$50,000
For grant recipient's exempt purposes
$15,000
HEALTH
$10,000
GENERAL OPERATING SUPPORT
$10,000
Showing up to 5 of 13 total records — full history available with membership.
Officers & Directors
SECRETARY
Andrew Jacobs
TREASURER
Jason Chang
BOARD MEMBER
J Martin Tenenbaum
BOARD MEMBER
Malachi Griffith
BOARD MEMBER
William Gillanders
PRESIDENT
William Hoos
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $4.8M | $4.6M | $3.1M |
| 2024 | $4.8M | $2.4M | $3.0M |
| 2023 | $2.5M | $2.3M | $938K |
| 2022 | $1.3M | $1.3M | $546K |
Between 2022 and 2025, reported annual revenue grew from $1.3M to $4.8M (+259%), with total assets most recently reported at $3.1M.
Interactive year-over-year charts and full filing details available with membership.